Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (Enalapril)

Fetnat M. Fouad, Robert C. Tarazi, Emmanuel L. Bravo, Stephen C. Textor

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (Enalapril)'. Together they form a unique fingerprint.

Medicine & Life Sciences